Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adicet Bio Inc
(NQ:
ACET
)
1.530
+0.100 (+6.99%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adicet Bio Inc
< Previous
1
2
3
4
5
6
7
Next >
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
January 25, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio, Inc. Announces Pricing of Public Offering
January 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Wedbush Maintains Outperform Rating for Adicet Bio: Here's What You Need To Know
November 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 22, 2024
Via
Benzinga
Adicet Bio, Inc. Announces Proposed Public Offering
January 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
January 22, 2024
IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these...
Via
Benzinga
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 09, 2024
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 09, 2024
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 05, 2024
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 04, 2024
Via
Benzinga
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
January 04, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
January 03, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
December 10, 2023
From
Adicet Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 08, 2023
Via
Benzinga
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach
November 27, 2023
Why Are Gamma-Delta T Cells Important In Fighting Cancer?
Via
Benzinga
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 08, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
November 07, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting
November 02, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
October 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
October 04, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
September 27, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Announces Appointment of Katie Peng to the Board of Directors
July 11, 2023
From
Adicet Bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.